217 related articles for article (PubMed ID: 31793333)
1. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
[TBL] [Abstract][Full Text] [Related]
2. Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates.
Kouta A; Hoppensteadt D; Bontekoe E; Jeske W; Duff R; Cera L; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620951851. PubMed ID: 33034200
[TBL] [Abstract][Full Text] [Related]
3. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
[No Abstract] [Full Text] [Related]
4. Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates.
Kouta A; Jeske W; Cera L; Farshid A; Duff R; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2021; 27():10760296211005544. PubMed ID: 33926250
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
[TBL] [Abstract][Full Text] [Related]
6. Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels.
Jeske W; Kouta A; Farooqui A; Siddiqui F; Rangnekar V; Niverthi M; Laddu R; Hoppensteadt D; Iqbal O; Walenga J; Fareed J
Front Med (Lausanne); 2018; 5():360. PubMed ID: 30687709
[No Abstract] [Full Text] [Related]
7. Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation.
Xie S; Guan Y; Zhu P; Li F; Yu M; Linhardt RJ; Chi L; Jin L
Carbohydr Polym; 2018 Oct; 197():83-91. PubMed ID: 30007661
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs.
Santos GRC; Tovar AMF; Capillé NVM; Pereira MS; Pomin VH; Mourão PAS
Drug Discov Today; 2014 Nov; 19(11):1801-1807. PubMed ID: 25019497
[TBL] [Abstract][Full Text] [Related]
9. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
Zhang B; Shi D; Li M; Shi F; Chi L
Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
[TBL] [Abstract][Full Text] [Related]
10. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
[TBL] [Abstract][Full Text] [Related]
12. Chemometric analysis of porcine, bovine and ovine heparins.
Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
[TBL] [Abstract][Full Text] [Related]
13. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
14. Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.
Tovar AM; Santos GR; Capillé NV; Piquet AA; Glauser BF; Pereira MS; Vilanova E; Mourão PA
Sci Rep; 2016 Oct; 6():35619. PubMed ID: 27752111
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
[TBL] [Abstract][Full Text] [Related]
16. Blended Heparin: A new Perspective to Guarantee the Supply of a Life-Saving Drug?
Guerrini M
Clin Appl Thromb Hemost; 2023; 29():10760296231173965. PubMed ID: 37170559
[TBL] [Abstract][Full Text] [Related]
17. Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins.
Naggi A; Gardini C; Pedrinola G; Mauri L; Urso E; Alekseeva A; Casu B; Cassinelli G; Guerrini M; Iacomini M; Baigorria V; Torri G
J Pharm Biomed Anal; 2016 Jan; 118():52-63. PubMed ID: 26512999
[TBL] [Abstract][Full Text] [Related]
18. Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine.
Glauser BF; Santos GRC; Silva JD; Tovar AMF; Pereira MS; Vilanova E; Mourão PAS
J Thromb Haemost; 2018 Sep; 16(9):1789-1799. PubMed ID: 29968421
[TBL] [Abstract][Full Text] [Related]
19. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
Levieux A; Rivera V; Levieux D
J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
